Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kent

Showing results (131-140 of 268) with videos related to

Pageof 27
Sort By:
Circulation. Heart Failure|August 13, 2016
Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External ValidationJenica N Upshaw, Marvin A Konstam, David van Klaveren, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 25, 2016
Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative DisordersAaron S Rosenberg, Robin Ruthazer, Jessica K Paulus, et al.
Kidney Medicine|April 7, 2022
Validation of a United Kingdom Model to Predict Mortality in Incident Dialysis Patients in the Dialysis Outcomes and Practice Patterns Study Cohort: Introduction of a Clinical Risk ScoreMartin Wagner, David M Kent, Ronald L Pisoni, et al.
Circulation. Cardiovascular Quality and Outcomes|July 9, 2015
Clinical Prediction Models for Cardiovascular Disease: Tufts Predictive Analytics and Comparative Effectiveness Clinical Prediction Model DatabaseBenjamin S Wessler, Lana Lai Yh, Whitney Kramer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 14, 2013
Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control studyIoannis Koulouridis, Mansour Alfayez, Hocine Tighiouart, et al.
Annals of Internal Medicine|January 7, 2015
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysisRaveendhara R Bannuru, Christopher H Schmid, David M Kent, et al.
International Journal of Cardiology. Heart & Vasculature|February 26, 2016
A predictive model to identify patients with suspected acute coronary syndromes at high risk of cardiac arrest or in-hospital mortality: An IMMEDIATE Trial sub-study<sup>,,.</sup>Madhab Ray, Robin Ruthazer, Joni R Beshansky, et al.
Mayo Clinic Proceedings|November 16, 2021
An Electronic Health Record-Compatible Model to Predict Personalized Treatment Effects From the Diabetes Prevention Program: A Cross-Evidence Synthesis Approach Using Clinical Trial and Real-World DataDavid M Kent, Jason Nelson, Anastassios Pittas, et al.
Journal of the American College of Cardiology|July 24, 2010
Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approachDaniel G Kramer, Thomas A Trikalinos, David M Kent, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant RecipientsBradley J Gardiner, Jennifer K Chow, Lori Lyn Price, et al.
Pageof 27

Showing results (131-140 of 268) with videos related to

Sort By:
Pageof 27
Circulation. Heart Failure|August 13, 2016
Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External ValidationJenica N Upshaw, Marvin A Konstam, David van Klaveren, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 25, 2016
Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative DisordersAaron S Rosenberg, Robin Ruthazer, Jessica K Paulus, et al.
Kidney Medicine|April 7, 2022
Validation of a United Kingdom Model to Predict Mortality in Incident Dialysis Patients in the Dialysis Outcomes and Practice Patterns Study Cohort: Introduction of a Clinical Risk ScoreMartin Wagner, David M Kent, Ronald L Pisoni, et al.
Circulation. Cardiovascular Quality and Outcomes|July 9, 2015
Clinical Prediction Models for Cardiovascular Disease: Tufts Predictive Analytics and Comparative Effectiveness Clinical Prediction Model DatabaseBenjamin S Wessler, Lana Lai Yh, Whitney Kramer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 14, 2013
Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control studyIoannis Koulouridis, Mansour Alfayez, Hocine Tighiouart, et al.
Annals of Internal Medicine|January 7, 2015
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysisRaveendhara R Bannuru, Christopher H Schmid, David M Kent, et al.
International Journal of Cardiology. Heart & Vasculature|February 26, 2016
A predictive model to identify patients with suspected acute coronary syndromes at high risk of cardiac arrest or in-hospital mortality: An IMMEDIATE Trial sub-study<sup>,,.</sup>Madhab Ray, Robin Ruthazer, Joni R Beshansky, et al.
Mayo Clinic Proceedings|November 16, 2021
An Electronic Health Record-Compatible Model to Predict Personalized Treatment Effects From the Diabetes Prevention Program: A Cross-Evidence Synthesis Approach Using Clinical Trial and Real-World DataDavid M Kent, Jason Nelson, Anastassios Pittas, et al.
Journal of the American College of Cardiology|July 24, 2010
Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approachDaniel G Kramer, Thomas A Trikalinos, David M Kent, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant RecipientsBradley J Gardiner, Jennifer K Chow, Lori Lyn Price, et al.
Pageof 27